Reply To: Traders Market Weekly: Short Squeezes and Bond Markets


CureVac (CVAC 10.46, +2.20, +26.6%): announces positive data on joint COVID-19 and Flu mRNA vaccine development programs
lululemon athletica (LULU 288.59, -40.67, -12.4%): provides mixed guidance ahead of ICR Conference
Visa (V 220.30, +2.55, +1.2%) and Mastercard (MA 373.50, +5.83, +1.6%): upgraded to Overweight from Sector Weight at KeyBanc
Uber (UBER 27.13, +0.73, +2.8%): upgraded to Overweight from Neutral at Piper Sandler
Macy’s (M 21.00, -1.13, -5.1%): provides Q4 guidance ahead of its ICR Conference; reiterates EPS outlook, expects to reach low-end to mid-point of revenue guidance; says it believes the consumer will continue to be pressured in 2023
CinCor Pharma (CINC 27.31, +15.53, +131.8%): to be acquired by AstraZeneca (AZN) for $26.00 per share in cash plus a non-tradable CVR of $10.00 per share in cash payable upon a specified regulatory submission of a baxdrostat product.
Albireo Pharma plc (ALBO 42.80, +19.98, +87.6%): to be acquired by Ipsen (IPSEY) for $42.00 per share plus CVR of $10.00 per share related to the U.S. FDA approval of Bylvay in biliary atresia
Amryt Pharma (AMYT 14.51, +7.50, +107.0%): plc to be acquired by Chiesi Farmaceutici S.p.A. for $14.50 per ADS
Life Time (LTH 12.34, -0.47, -3.7%): sees Q4 revs below consensus